市場調查報告書
商品編碼
1284230
到 2028 年的患者監護市場預測——按設備類型、應用、最終用戶和地區進行的全球分析Patient Monitoring Market Forecasts to 2028 - Global Analysis By Device Type, Application, End User and By Geography |
據 Stratistics MRC 預計,到 2022 年,全球患者監護市場將達到 423 億美元,預測期內以 9.1% 的複合年增長率增長,到 2028 年將達到 713.3 億美元。
患者監測系統是醫療保健專業人員監測患者健康的一系列工具。 這些設備,也稱為遠程生理監測,經常用於遠程患者監測。 一組儀器和機器,用於跟蹤和記錄患者健康狀況的變化,同時使用各種生命體徵和警報系統持續監測患者。 患者不再需要經常去看醫生,僅此一項就可以省錢。 它還可以對患者護理計劃進行適當調整,並增強數據驅動的臨床決策。
根據世界衛生組織 (WHO) 的數據,全世界約有 4.22 億人患有糖尿病,約 2.35 億人患有哮喘。
現有醫療保健系統的可持續性是世界各國政府的主要關注點。 由於醫療費用的增加,尤其是在醫院,重點是替代療法,如家庭護理。 遠程監控和家庭監控設備的使用增加顯著減少了再入院率。 對胎兒和新生兒監護儀、溫度監護儀、脈搏血氧儀、EEG 記錄儀、事件和 ECG 監護儀等有效家庭技術的需求不斷增長,這推動了市場需求。
降低醫療保健成本的國際努力包括價格監管、競爭性定價、招標和合同程序、保險範圍和支付政策、藥物療效比較、技術評估和管理式醫療系統。有。 稅收預計將推高運營成本,並對全球主要醫療保健市場的醫療器械業務的現金流產生不利影響。
可穿戴患者監測設備的應用包括連續血糖監測、溫度監測、血壓監測和脈搏血氧儀。 物聯網可用於新一代可穿戴技術。 隨著無線數據傳輸網絡變得更好和更廣泛可用,用於遠程醫療和更好的患者監控的平台將變得更容易設計。 可穿戴生物傳感器的增加推動了市場需求。
有缺陷的硬件或糟糕的規劃可能會導致系統失敗,因此擁有一種預測和解決系統故障的方法非常重要。 特別是,對於安全關鍵型應用,例如與人類健康相關的患者監護設備,有關係統故障的風險分析應被視為必不可少的。 這一點威脅到對產品的需求。
在 COVID-19 大流行期間,世界各地都實行了社會隔離和檢疫措施。 因此,許多人避免了頻繁去醫院就診。 因此,每天檢測家中的溫度和氧氣濃度,掌握健康狀況就變得清晰起來。 可穿戴技術可以通過整合臨床症狀和生命指標來幫助識別許多慢性疾病。 因此,使用可穿戴技術來對抗 COVID-19 的情況急劇增加。
據估計,血糖監測設備領域將實現利潤豐厚的增長。 血糖監測裝置包括自我監測和連續監測裝置。 糖尿病患病率和患病率的增加,以及新產品的推出和發展中國家血糖監測設備使用的增加,預計將推動這一領域的擴張。
在預測期內,醫院和診所部門預計將以最快的複合年增長率增長。 許多患者群體更喜歡醫院和診所,尤其是在新興國家。 此外,在醫院進行的手術數量不斷增加,以及醫院為引進高科技患者監護設備提供的資金支持,也為市場佔有很大份額做出了貢獻。
由於傳染病數量龐大,亞太地區預計在預測期內將佔據最大的市場份額。 該地區老年人口眾多,許多公營和私營公司都在大力投資醫療保健基礎設施。 醫院基礎設施的擴建和門診手術中心的增加也有望推動亞太地區的市場。
預計北美在預測期內的複合年增長率最高。 慢性病的發病率和流行率在北美急劇增加。 北美是 GE Healthcare、Edward Lifesciences、Masimo Corporation 和 Natus Medical 等主要製造商的所在地。 這些製造商正在投資研發和建造設施,以生產更現代的患者監護設備。 人口增長和降低醫療成本的需求增加推動了這一領域的市場擴張。
2022 年 9 月,全球領先的醫療技術、診斷和數字解決方案創新者 GE Healthcare 將推出首款“印度製造”、“人工智能驅動”的產品,以推進印度的心臟護理。宣布推出 Catlab -Optima IGS 320。
2022 年 7 月,強生消費者健康部宣布推出經環境工作組 (EWG) 認證的嬰兒護膚和護髮品牌 Vivvi & Bloom。 該品牌是與千禧一代和 Gen-Z 的父母和看護人社區共同創建的,名為“The Village”,集思廣益他們想要什麼。
2022 年 4 月,飛利浦醫療推出了配備先進聲波技術的飛利浦 Sonicare 系列電動牙刷的新產品。 它去除牙菌斑的效果是手動牙刷的 3 到 7 倍。
According to Stratistics MRC, the Global Patient Monitoring Market is accounted for $42.3 billion in 2022 and is expected to reach $71.33 billion by 2028 growing at a CAGR of 9.1% during the forecast period. A patient monitoring system is a collection of tools that allow medical personnel to keep tabs on a patient's wellbeing. These devices, which are also known as remote physiologic monitoring, are frequently employed for remote patient monitoring. It is a group of devices or pieces of machinery used to track and record changes in patients' welfare while continuously monitoring them using a variety of vital signs and warning systems. Patients don't need to see a doctor as frequently, which saves money on its own. It enables appropriate adjustments to the patient's care plan and enhances data-driven clinical decision making.
According to the World Health Organization (WHO), about 422 million people globally have diabetes and around 235 million people suffer from asthma.
For governments all across the world, the sustainability of the existing healthcare system is a major issue of concern. The emphasis is now on alternate treatment modalities like home healthcare because of the growing healthcare costs, particularly in hospital settings. The usage of remote and home monitoring devices has increased, which has resulted in a significant reduction in hospital readmissions. An increase in the need for effective home-use technology, such as fetal and neonatal monitors, temperature monitors, pulse oximeters, EEG recorders, and event and ECG monitors, is accelerating the market demand.
A few of the international efforts being made to lower healthcare costs include price regulations, competitive pricing, bidding and contract procedures, coverage and payment policies, comparative efficacy of medications, technology assessments, and managed-care arrangements. Taxes are predicted to push up operational expenses and adversely impact medical device businesses cash flow in the world's main healthcare markets.
Applications for wearable patient monitoring devices include continuous glucose monitoring, temperature monitoring, blood pressure monitoring, and pulse oximetry. The Internet of Things is available on newer generations of wearable technologies. Platforms for telehealth and better patient monitoring will be easier to design as wireless data transmission networks get better and are more widely available. The market demand is being propelled by the increase in wearable biosensors.
Systems might fail due to faulty hardware or inadequate planning, thus it's critical to establish methods for anticipating and resolving system failures. Risk analysis related to system failures should be viewed as essential, especially for safety-critical applications like patient monitoring devices that deal with human health. This aspect is threatening the demand of the product.
Social segregation and quarantining practices have been used all across the world during the COVID-19 pandemic. As a consequence, many individuals avoided frequent hospital visits. This highlighted the necessity of routinely checking their home's temperature and oxygen levels to keep track on their health. Wearable technology aids in the identification of many chronic illnesses by merging clinical symptoms with vital indications. As a result, the use of wearable technologies to combat COVID-19 has dramatically increased.
The blood glucose monitoring devices segment is estimated to have a lucrative growth. Blood glucose monitoring systems include self-monitoring glucose systems and continuous monitoring systems. The introduction of new products and the expanding use of blood glucose monitoring equipment in developing nations, together with the rising incidence and prevalence of diabetes, are anticipated to drive sector expansion.
The hospitals & clinics segment is anticipated to witness the fastest CAGR growth during the forecast period. A large target patient population especially in emerging economies mostly prefers hospitals and clinics. The growing volume of procedures in hospital settings, and the financial support provided by hospitals for the introduction of various technologically advanced patient monitoring device products are all factors contributing to the large share of this market.
Asia Pacific is projected to hold the largest market share during the forecast period owing to huge prevalence of infectious illnesses. This region has large geriatric population and many and favourable public and private players are making huge investments on healthcare infrastructure. In addition, the expansion of hospital infrastructure and the rise in the number of ambulatory surgery centers are anticipated to drive the APAC region market.
North America is projected to have the highest CAGR over the forecast period. In North America, the incidence and prevalence of chronic illnesses are dramatically increasing. There are significant manufacturers notably GE Healthcare, Edward Lifesciences, Masimo Corporation and Natus Medical. They are investing on R&D to build facilities for more modern patient monitoring devices. The market expansion in this area is being accelerated by the expanding population and the growing demand to save healthcare costs.
Some of the key players profiled in the Patient Monitoring Market include Abbott Laboratories, SCHILLER , Biotelemetry, Inc, Baxter International Inc, BIOTRONIK, Shenzhen Mindray Bio-Medical, Natus Medical Medtronic plc, Boston Scientific Corporation, Edwards Lifesciences Corporation, Masimo Corporation, Compumedics Limited Electronics Co., Ltd, OMRON Corporation, Nonin, GE Healthcare, Johnson & Johnson, Medtronic PLC, Koninklijke Philips NV, Becton, Dickinson and Company, Smiths Medical and Philips Healthcare.
In September 2022, GE Healthcare, a leading global medical technology, diagnostics and digital solutions innovator announced the launch of its first 'Made in India', 'AI-powered' Cath lab - Optima IGS 320 to advance cardiac care in India.
In July 2022, Johnson & Johnson Consumer Health has unveiled Vivvi & Bloom, an Environmental Working Group (EWG) certified skin and hair care brand for babies and toddlers. The brand was co-created with a community called "The Village", including Millennial and Gen-Z parents as well as caregivers who gave their input about what they wanted.
In April 2022, Philips Healthcare launched the new Philips Sonicare range of electric toothbrush series that features advanced sonic technology. It provides three to seven times better plaque removal as compared to manual toothbrushes.